Patient Pulse

Evolve MI and Pragmatic Clinical Trials with Dr. Christopher Cannon

Thomas Nero, MD Episode 7

Let us know your thoughts. We would love to hear from you.

Dr Christopher Cannon discusses the EVOLVE-MI trial to decrease cholesterol with  Evolocumab early after Myocardial Infarction as well as the rational for a less intensive way to study patients with open label, pragmatic clinical trials.